EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral activities of hemp cannabinoids

Richard B van Breemen iD, Daniel Simchuk

Clinical Science · 2023

DOI: 10.1042/cs20220193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2023. Verfasst von Richard B van Breemen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, Global Hemp Innovation Center, Oregon State University, 2900 SW …. Hauptthemen laut MEDLINE: Cannabis, COVID-19, Cannabinoids, Cannabidiol. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemp is an understudied source of pharmacologically active compounds and many unique plant secondary metabolites including more than 100 cannabinoids. After years of legal restriction, research on hemp has recently demonstrated antiviral activities in silico, in vitro, and in vivo for cannabidiol (CBD), Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), and several other cannabinoids against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), human immunodeficiency virus (HIV), and γ-herpes viruses. Mechanisms of action include inhibition of viral cell entry, inhibition of viral proteases, and stimulation of cellular innate immune responses. The anti-inflammatory properties of cannabinoids are also under investigation for mitigating the cytokine storm of COVID-19 and controlling chronic inflammation in people living with HIV. Retrospective clinical studies support antiviral activities of CBD, Δ9-THC, and cannabinoid mixtures as do some prospective clinical trials, but appropriately designed clinical trials of safety and efficacy of antiviral cannabinoids are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisCOVID-19CannabinoidsCannabidiolHIV InfectionsHumansProspective StudiesRetrospective StudiesSARS-CoV-2

Stichwörter der Autor:innen

COVID-19HIVSARS-CoV-2antiviralcannabinoidsherpesvirus

Substanzen

CannabinoidsCannabidiol

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, Global Hemp Innovation Center, Oregon State University, 2900 SW Campus Drive, Corvallis, OR 97331, U.S.A.

ORCID-Profile: Richard B van Breemen

Zitieren

APA

van Breemen, R. B., & Simchuk, D. (2023). Antiviral activities of hemp cannabinoids. Clinical Science. https://doi.org/10.1042/cs20220193

Vancouver

van Breemen RB, Simchuk D. Antiviral activities of hemp cannabinoids. Clinical Science. 2023. doi:10.1042/cs20220193

BibTeX
@article{vanBreemen2023,
  author = {van Breemen, Richard B and Simchuk, Daniel},
  title = {Antiviral activities of hemp cannabinoids},
  journal = {Clinical Science},
  year = {2023},
  doi = {10.1042/cs20220193}
}
Kostenlos starten →